{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:44:08Z","timestamp":1790876648146,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejps.2022.106165","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T12:10:04Z","timestamp":1646827804000},"page":"106165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Application of tiny-TIM as a mechanistic tool to investigate the in vitro performance of different itraconazole formulations under physiologically relevant conditions"],"prefix":"10.1016","volume":"173","author":[{"given":"\u00c1lvaro","family":"L\u00f3pez M\u00e1rmol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina L.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schw\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1385-182X","authenticated-orcid":false,"given":"Mirko","family":"Koziolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106165_bib0001","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1002\/jps.24177","article-title":"Application and Validation of an Advanced Gastrointestinal In Vitro Model for the Evaluation of Drug Product Performance in Pharmaceutical Development","volume":"103","author":"Barker","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejps.2022.106165_bib0002","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1128\/AAC.42.7.1862","article-title":"Enhanced Bioavailability of Itraconazole in Hydroxypropyl\u03b2-Cyclodextrin Solution versus Capsules in Healthy Volunteers","volume":"42","author":"Barone","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejps.2022.106165_bib0003","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.foodres.2016.01.030","article-title":"Development of an advanced in vitro model of the stomach and its evaluation versus human gastric physiology","volume":"88","author":"Bellmann","year":"2016","journal-title":"Food Res Int"},{"key":"10.1016\/j.ejps.2022.106165_bib0004","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.xphs.2020.08.008","article-title":"A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive?","volume":"109","author":"Bennett-Lenane","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejps.2022.106165_bib0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2017.04.057","article-title":"Gastrointestinal behavior of itraconazole in humans - Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solution","volume":"526","author":"Berben","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0006","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5599\/admet.686","article-title":"Perspectives in solubility measurement and interpretation","volume":"7","author":"Bergstr\u00f6m","year":"2019","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejps.2022.106165_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105497","article-title":"Sub)micron particles forming in aqueous dispersions of amorphous solid dispersions of the poorly soluble drug ABT-199: A combined particle optical counting and field-flow fractionation study","volume":"154","author":"Bohsen","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ejps.2022.106165_bib0008","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1021\/acs.molpharmaceut.9b00406","article-title":"Prediction of Bioequivalence and Food Effect Using Flux-and Solubility-Based Methods","volume":"16","author":"Borb\u00e1s","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.104967","article-title":"Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems","volume":"137","author":"Boyd","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ejps.2022.106165_bib0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijpharm.2017.04.029","article-title":"Gastrointestinal behavior of itraconazole in humans \u2013 Part 1: Supersaturation from a solid dispersion and a cyclodextrin-based solution","volume":"525","author":"Brouwers","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2018.12.010","article-title":"In vitro models for the prediction of in vivo performance of oral dosage forms: recent progress from partnership through the IMI OrBiTo collaboration","volume":"136","author":"Butler","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0012","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4155\/ipk-2016-0026","article-title":"Effect of food on abiraterone pharmacokinetics: a review","volume":"2","author":"Chien","year":"2017","journal-title":"Int J Pharmacokinet"},{"key":"10.1016\/j.ejps.2022.106165_bib0013","doi-asserted-by":"crossref","first-page":"11314","DOI":"10.1021\/jf902392a","article-title":"Combining the dynamic TNO-gastrointestinal tract system with a Caco-2 cell culture model: Application to the assessment of lycopene and \u03b1-tocopherol bioavailability from a whole food","volume":"57","author":"D\u00e9at","year":"2009","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.ejps.2022.106165_bib0014","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0016-5085(82)80145-5","article-title":"Analysis of Gastric Emptying Data","volume":"83","author":"Elashoff","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2022.106165_bib0015","unstructured":"FDA. Patient Information of SPORANOX \u00ae (itraconazole) Oral Solution, 2011. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020657s025lbl.pdf (accessed 11\/02\/2021)."},{"key":"10.1016\/j.ejps.2022.106165_bib0016","unstructured":"FDA. Patient Information of SPORANOX \u00ae (itraconazole) Capsules, 2009. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020083s040s041s044lbl.pdf. (accessed 11\/02\/2021)."},{"key":"10.1016\/j.ejps.2022.106165_bib0017","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1021\/mp4003249","article-title":"Mechanistic understanding of the effect of PPIs and acidic carbonated beverages on the oral absorption of itraconazole based on absorption modeling with appropriate in vitro data","volume":"10","author":"Fotaki","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002280050438","article-title":"Effect of omeprazole on the pharmacokinetics of itraconazole","volume":"54","author":"Jaruratanasirikul","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejps.2022.106165_bib0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejpb.2019.01.026","article-title":"Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule","volume":"136","author":"Koziolek","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0021","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2019.04.003","article-title":"The mechanisms of pharmacokinetic food-drug interactions \u2013 A perspective from the UNGAP group","volume":"134","author":"Koziolek","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ejps.2022.106165_bib0022","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/j.1552-4604.1997.tb04332.x","article-title":"Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers","volume":"37","author":"Lange","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ejps.2022.106165_bib0023","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jps.20767","article-title":"Development and Validation of a Preclinical Food Effect Model","volume":"96","author":"Lentz","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejps.2022.106165_bib0024","series-title":"The Impact of Food Bioactives on Health: in vitro and ex vivo models","first-page":"37","article-title":"The TNO Gastro-Intestinal Model (TIM)","author":"Minekus","year":"2015"},{"key":"10.1016\/j.ejps.2022.106165_bib0026","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3565(24)29580-X","article-title":"Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption","volume":"297","author":"Paulson","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejps.2022.106165_bib0027","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejpb.2020.02.003","article-title":"On the usefulness of compendial setups and tiny-TIM system in evaluating the in vivo performance of oral drug products with various release profiles in the fasted state: Case example sodium salt of A6197","volume":"149","author":"Schilderink","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0018","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijpharm.2016.07.063","article-title":"Displacement of itraconazole from cyclodextrin complexes in biorelevant media: In vitro evaluation of supersaturation and precipitation behavior","volume":"511","author":"Stappaerts","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0028","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/j.1875-9114.1996.tb02973.x","article-title":"Effect of food on the pharmacokinetics of a new hydroxypropyl-\u03b2-cyclodextrin formulation of itraconazole","volume":"16","author":"Van De Velde","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejps.2022.106165_bib0029","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1200\/JCO.2015.65.2560","article-title":"Influence of the acidic beverage cola on the absorption of erlotinib in patients with non-small-cell lung cancer","volume":"34","author":"Van Leeuwen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejps.2022.106165_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00558308","article-title":"The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects","volume":"36","author":"Van Peer","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejps.2022.106165_bib0031","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2015.11.048","article-title":"Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms","volume":"498","author":"Verwei","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejps.2022.106165_bib0032","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.drudis.2016.03.002","article-title":"Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors","volume":"21","author":"Willemsen","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ejps.2022.106165_bib0033","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/clpt.2014.87","article-title":"pH-Dependent Drug-Drug Interactions for Weak Base Drugs: Potential Implications for New Drug Development","volume":"96","author":"Zhang","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejps.2022.106165_bib0034","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00199879","article-title":"Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole","volume":"46","author":"Zimmermann","year":"1994","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:01:08Z","timestamp":1760529668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"alternative-id":["S0928098722000501"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106165","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of tiny-TIM as a mechanistic tool to investigate the in vitro performance of different itraconazole formulations under physiologically relevant conditions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AbbVie Deutschland GmbH & Co. KG. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106165"}}